Halozyme Therapeutics Inc. (HALO)

$ 0.00
   
  • Closing Price Chg:
    $-0.78
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 0
  • RiskGrade: 189

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,691.05 1,090.47 819.20¢ 8.6 0.3 +31% n/a 0.0%
31-Dec-27 1,909.55 1,307.58 962.50¢ 7.3 0.4 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 70.43
Closing Price Change $ -0.78
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 145.30m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page